BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 17401022)

  • 1. CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.
    Hammond AL; Waller EK; Finkelstein LB
    J Clin Oncol; 2007 Apr; 25(10):1288; author reply 1288. PubMed ID: 17401022
    [No Abstract]   [Full Text] [Related]  

  • 2. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
    Dilts DM; Sandler AB
    J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of geriatric principles in oncology clinical trials.
    Hurria A
    J Clin Oncol; 2007 Dec; 25(34):5350-1. PubMed ID: 18048814
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase 0 clinical studies in oncology.
    Collins JM
    Clin Pharmacol Ther; 2009 Feb; 85(2):204-7. PubMed ID: 19109589
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathology is a necessary and informative tool in oncology clinical trials.
    Nagtegaal ID; West NP; van Krieken JH; Quirke P
    J Pathol; 2014 Jan; 232(2):185-9. PubMed ID: 24037805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.
    Ratain MJ; Karrison TG
    Clin Cancer Res; 2007 Feb; 13(3):781-2. PubMed ID: 17289865
    [No Abstract]   [Full Text] [Related]  

  • 7. Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.
    Steensma DP
    J Clin Oncol; 2007 Mar; 25(9):1148; author reply 1148-9. PubMed ID: 17369584
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of genomics in clinical trial design.
    Simon R
    Clin Cancer Res; 2008 Oct; 14(19):5984-93. PubMed ID: 18829477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mentoring of research associates in the Southwest Oncology Group (SWOG)--quality assurance in clinical trials.
    Davis B
    J Oncol Manag; 2003; 12(2):30-1. PubMed ID: 12699114
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction.
    Lin DW; Shore ND
    Urol Oncol; 2012; 30(4 Suppl):S1. PubMed ID: 22795074
    [No Abstract]   [Full Text] [Related]  

  • 11. [Randomized clinical trials].
    Dvoĭrin VV
    Vopr Onkol; 1982; 28(4):70-2. PubMed ID: 7090274
    [No Abstract]   [Full Text] [Related]  

  • 12. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
    Gray SW; Hlubocky FJ; Ratain MJ; Daugherty CK
    J Clin Oncol; 2007 Aug; 25(23):3488-94. PubMed ID: 17687154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trials in oncology and elderly patients].
    Moncenix G
    Soins Gerontol; 2003; (44):39. PubMed ID: 14648943
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical oncologists' participation in cancer clinical trials.
    Spaight SJ; Nash S; Finison LJ; Patterson WB
    Prog Clin Biol Res; 1984; 156():49-61. PubMed ID: 6473452
    [No Abstract]   [Full Text] [Related]  

  • 15. The ethical approach to randomization in oncology.
    Arpaillange P; Dion S
    Drugs Exp Clin Res; 1986; 12(1-3):99-103. PubMed ID: 3732058
    [No Abstract]   [Full Text] [Related]  

  • 16. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
    J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research plan for radiation oncology--1987: design and analysis of clinical trials.
    Davis LW; Bauer M
    Am J Clin Oncol; 1988 Jun; 11(3):404-10. PubMed ID: 3381761
    [No Abstract]   [Full Text] [Related]  

  • 18. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to special issue on biomarker-based clinical trial designs in oncology.
    Sargent DJ; Mandrekar S; Grothey A
    Chin Clin Oncol; 2015 Sep; 4(3):28. PubMed ID: 26408295
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric clinical trials: experiences of the Children's Oncology Group.
    Auger N
    Can Oncol Nurs J; 2003; 13(3):187. PubMed ID: 14508908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.